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Eradication of bovine viral diarrhea virus (BVDV) is ongoing in many European countries
and is based on removal of persistently infected (PI) cattle. In this context, low-level
risks, including alternative reservoirs of infection, may become more important as the
number of BVDV-free herds increases. Alternative reservoirs include livestock, such as
sheep and goats, as well as wildlife, including deer and rabbits. Due to the extensive
nature of the beef industry in Scotland, where an eradication program started in 2010,
contact between cattle and alternative reservoir hosts is common. Seroprevalence to
BVDV in rabbit populations can be high. In addition, rabbits can be infected with
BVDV by natural routes, indicating that they could be a wildlife reservoir of infection.
We analyzed the potential risk to livestock from rabbit populations in the UK by two
approaches. First, ∼260 serum samples from free-ranging wild rabbits in Scotland
and northern England were tested for BVDV-specific antibodies by ELISA. Only three
samples exhibited low level BVDV-specific reactivity, suggesting that BVDV infection of
rabbits was not frequent. Second, rabbits were challenged with BVDV at day 7 or 12
of pregnancy. This did not lead to any clinical signs in the infected animals or obvious
increases in abortion or stillbirth in the infected dams. Samples from the dams, placental
material and ∼130 offspring were tested by BVDV-specific RT-PCR and antibody ELISA.
Positive PCR results in the placentas and in the tissues and body fluids of rabbits up to
10 days old showed that trans-placental infection of rabbits with BVDV had occurred.
Many of the offspring had BVDV-specific antibodies. These data support the view that
a wildlife reservoir of BVDV in rabbit poses a small but non-zero risk of re-infection for
BVDV-free cattle herds. Rabbits are susceptible to infection with BVDV but only a small
proportion of free-living rabbits in the UK appear to have been infected.
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Introduction
Bovine viral diarrhea (BVD) is an endemic disease, caused by
bovine viral diarrhea virus (BVDV), with a signiﬁcant impact
on cattle production and health due to the abortifacient and
immunosuppressive eﬀects of infection. Maintenance in the UK
herd is driven by persistently infected (PI) animals that were
infected in utero, so that they tolerate BVDV infection and shed
virus continuously.
Bovine viral diarrhea virus PI animals may show no
clinical signs as calves, however, they often have a reduced
growth rate and productivity and their life-expectancy is
signiﬁcantly reduced. Herds with BVDV generally have reduced
reproductive performance and a higher rate of diseases such
as diarrhea and pneumonia (Evermann and Faris, 1981) as a
consequence of BVDV related immunsuppresion. Because of
the economic losses due to BVDV infection, many European
countries have undertaken eradication programs. Pioneered
by Scandinavian countries, national compulsory eradication
programs are ongoing in Austria, Switzerland, Germany, Ireland,
and Scotland and are based on detection and removal of PI
animals with or without vaccination of uninfected animals in
the herd (Stahl and Alenius, 2012). In several other countries,
regional and voluntary programs exist.
Scotland has a BVD eradication program based on the
identiﬁcation of PI cattle and the restriction of their sale or
movement. However, ﬂaws in the design or implementation of
control programs and potential spread from wildlife reservoirs
may impact Scotland’s ability to become and remain BVD-free.
Bovine viral diarrhea virus can cross the species barrier
relatively easily, particularly into sheep, where it causes a disease
clinically indistinguishable from that caused by Border Disease
Virus (Carlsson, 1991). Antibodies against BVDV have been
detected in a wide range of wild and domesticated ruminant and
porcine species (Doyle and Heuschele, 1983; Becher et al., 1997;
Scherer et al., 2001; Van Campen et al., 2001) and persistent
infection has been demonstrated in sheep, goats, pigs, alpaca,
white-tailed deer, eland, mouse deer, and American mountain
goats (Terpstra and Wensvoort, 1997; Vilcek et al., 2000; Scherer
et al., 2001; Carman et al., 2005; Uttenthal et al., 2005; Passler
et al., 2010; Bachofen et al., 2013a). In the early years of BVDV
research, a wide range of non-artiodactyls such as horses, cats,
dogs, several small laboratory animal species (guinea pig, mouse,
rabbit) and embryonated chicken eggs were inoculated with the
virus in order to determine the host range (Baker et al., 1954). The
only non-artiodactyl animal in which virus could be propagated
upon intravenous inoculation was the rabbit. These authors
reported (Baker et al., 1954) that calves inoculated with spleen
homogenate from rabbits that had been infected with BVDV
5 days earlier showed clinical signs typical of transient BVDV
infection. Furthermore, BVDV could be serially passaged, both
within rabbits and between rabbits and cattle, using lymphoid
cell suspensions (Baker et al., 1954). More recently, a serological
survey in Germany showed that 40% of sera sampled from 100
wild rabbits exhibited low neutralizing antibody titres against
BVDV (Frolich and Streich, 1998). However, only a third of
the positive results could be conﬁrmed by ELISA and no virus
could be isolated from any rabbit. A recent experimental study
has demonstrated that rabbits can be infected with BVDV by
both parenteral and natural routes but shedding of virus was
not detected (Bachofen et al., 2014). Thus, there are indications
that rabbits could be a natural wildlife reservoir for BVDV.
Since rabbits are abundant in countries such as the United
Kingdom and Ireland, often living on or near livestock pastures,
a BVDV reservoir in rabbits could have signiﬁcant consequences
for BVDV eradication campaigns in these countries, especially
toward the end of an eradication scheme. In this study we have
used a serological survey of free-ranging wild rabbit populations
and experimental infection of pregnant rabbits to determine
whether BVDV infected rabbits pose a risk to in-contact livestock.
Materials and Methods
Ethics Statement
This study was conducted in the UK in compliance with the
Home Oﬃce of Great Britain and Northern Ireland ‘Animals
(Scientiﬁc Procedures) Act 1986’ and with the approval of the
Moredun Research Institute Experiments and Ethical Review
Committee (E53/14).
Virus
The BVDV isolate (MRI103) used for the experimental exposures
was isolated from the serum of a Scottish PI bovid which was
free of maternal antibodies, and passaged six times on bovine
turbinate (BT) cells. After three passages, the virus was titrated
on BT cells and a multiplicity of infection (MOI) of 0.01 was used
for the following passages as previously described (Frolich and
Streich, 1998). Medium from the sixth passage, containing BVDV
at a titre of 106 TCID50/mL, was clariﬁed by centrifugation at
4000 × g for 30 min and stored in aliquots at −80◦C before
use. All cells, tissue culture medium (Iscove’s modiﬁed Dulbecco’s
medium, IMDM; Sigma–Aldrich, Dorset, UK) and foetal bovine
serum (FBS) used were tested free of pestivirus and antibodies
against pestivirus. The 5′UTR and Npro coding region of the
isolate were sequenced for phylogenetic typing as previously
described (Bachofen et al., 2013b) and MRI103 was determined
to be a BVDV-1a virus.
Animals and Treatments
Twentymated femaleNewZealandWhite rabbits were purchased
from a certiﬁed breeder with an 80% likelihood of pregnancy,
for delivery on estimated day 5 of gestation. The rabbits were
acclimatized for 2 days prior to being assigned randomly into two
groups of eight animals and one group of four animals that were
housed in individual boxes, with each group in a separate room.
In cattle, BVDV infection during the ﬁrst 120 days of pregnancy
is thought to result in persistent infection of the fetus (Charleston
et al., 2001). Therefore, in challenging pregnant rabbits we used
two time points that were within the same portion of the rabbit
gestation period (up to day 13). The two groups of eight rabbits
were exposed to BVDV intravenously on day 7 (Group 1) or day
12 (Group 2) of gestation via the ear vein with 1ml of virus (106
TCID50) whilst the remaining four rabbits (Group 3) were mock
Frontiers in Microbiology | www.frontiersin.org 2 September 2015 | Volume 6 | Article 1000
Grant et al. Trans-placental BVDV infection of rabbits
infected with 1 ml of IMDM. A pre-infection blood sample was
also collected from each animal. The inoculum of 106 TCID50
had previously been used to induce transient infection in rabbits
(Bachofen et al., 2014). One animal from Group 2 and one animal
from Group 3 had to be withdrawn from the experiment due to
issues with subsequent sampling. The body temperature of each
animal was monitored daily by a subcutaneous microchip placed
in the neck region (idENTICHIP; Animalcare, York, UK). The
animals were observed twice daily until the delivery of the ﬁrst
oﬀspring after which observations were made four times a day.
Nesting material was included in all boxes and any live oﬀspring
found outside the nest were recovered to it. Any dead oﬀspring
or placental tissues found in the boxes were collected and frozen
for later analysis. All remaining animals were euthanized at
the end of the study (approximately day 10 after birth of the
oﬀspring).
At post-mortem examination, samples of lung, heart, liver,
spleen, kidney, ileum (sacculus rotundus) and appendix were
placed into neutral buﬀered formal saline, processed routinely
through graded alcohols prior to being embedded in paraﬃn
wax and stored at 4◦C until required. For detection of
BVDV viral RNA, tissue samples were collected into RNAlater
(Life Technologies, Paisley, UK). Blood samples were collected
post mortem by cardiac puncture and were allowed to clot
before drawing oﬀ serum, while urine samples were taken
directly from the bladder. Samples of serum and urine were
frozen under aseptic conditions and stored at −80◦C until
required.
RNA Isolation and BVDV Real-Time RT-PCR
RNA isolation from blood or body ﬂuid samples was performed
using a viral RNA mini kit (Qiagen, Manchester, UK)
according to the manufacturer’s instructions. For tissue samples,
homogenisation of about 30 mg of frozen tissue by ceramic beads
in RLT buﬀer (Qiagen) using the Precellys 24 tissue homogenizer
was followed by RNA isolation using the RNeasy mini kit
(Qiagen).
Buﬀy coats from blood samples were isolated using a
commercial red cell lysis buﬀer (Promega, Southampton, UK).
Subsequent RNA isolation was performed using QIAShredder
columns and the RNeasy mini kit (Qiagen).
For simultaneous detection of the viral genome and host
beta-actin RNA, an established BVDV-1 speciﬁc real time
RT-PCR (Willoughby et al., 2006) was used with a generic
actin assay (Crook et al., 2012) in a duplex assay on an
ABI 7500 sequence detection system (Applied Biosystems-
Life Technology, Paisley, UK). Virus-positive RNA samples
(Ct < 40) were retested to conﬁrm the result. Additionally, end-
point PCR ampliﬁcation of BVDV RNA directly from serum
or urine was performed as described previously (Bachofen
et al., 2013b) and the PCR products were characterized by
capillary electrophoresis in a commercial instrument (Qiaxcel,
Qiagen).
Sample Collection from Wild Rabbits
Serum samples were obtained from wild rabbits shot at three
locations in the UK as described previously (Boag et al., 2001,
2013). The majority of samples came from a 400 ha site in
Perthshire, Scotland (182; 2008–2011, Figure 1), while others
were obtained in North Yorkshire, England (31; 2004–2009) and
the island of Coll, Scotland (45; 1985–2014). Serum samples
were stored at −20◦C until required for analysis of serological
responses to BVDV antigens.
ELISA for Detection of BVDV Antibodies
A biphasic, indirect antibody capture ELISA was used to
detect BVDV antibodies in serum samples. The test was used
essentially as described previously (Bachofen et al., 2014). Brieﬂy,
alternate columns of a 96-well ELISA plate (high binding,
Greiner Bio-One, Gloucestershire, UK) were coated with antigen
from Igepal treated BVDV (isolate C24V) infected cells or
with an equivalent antigen preparation from uninfected cells.
Prior to usage, plates were blocked for 45 min at room
temperature with a solution of 4% milk powder in phosphate
buﬀered saline (PBS) containing 0.05% Tween20 (PBST). The
rabbit serum samples were diluted 1:50 in PBST containing
2% milk powder and added in quadruplicates to the plate.
After incubation (1 h) and washing, the horseradish peroxidase
(HRP) conjugated anti-rabbit Ig antibody was added (P0448;
Goat anti-rabbit immunoglobulins/HRP, diluted at 1:1000;
Dako UK, Cambridgeshire, UK). Following a further 1 h
incubation and a wash step, bound antibody was visualized
by adding tetramethylbenzidine substrate (SureBlue, KPL Inc.,
Gaithersburg, USA). The reaction was stopped after 5 min by
addition of 0.18 M sulphuric acid and absorbance at 450 nm
was measured in an ELISA plate reader (Dynex MRXII, Dynex
Technologies, West Sussex, UK). Aliquots of positive terminal
serum from BVDV-infected rabbits from a previous experiment
were used as positive control, while serum from mock-infected
rabbits was used as the negative control (Bachofen et al., 2014).
Plate to plate variation was normalized by calculation of the
sample to positive (S/P) ratio for each sample relative to the
positive and negative control serum on each plate. The following
formula was used to calculate S/P values, where the corrected
OD is the mean OD of positive antigen wells minus the mean
OD of the negative antigen wells inoculated with the same
sample:
S/P = (correctedOD of sample − correctedOD of negative control)
(correctedOD of positive control − correctedOD of negative control)
For each ELISA sample set, a cut-oﬀ for positive samples was
calculated based on all samples (free-ranging rabbits) or on the
negative control Group 3 (experimentally infected rabbits) as the
arithmetic mean plus 3 standard deviations.
Histopathology and Immunohistochemistry
(IHC)
Paraﬃn-wax embedded tissue sections were cut (5µm), mounted
on glass microscope slides and stained with haematoxylin and
eosin (H&E) prior to evaluation by light microscopy. Selected
tissue sections from oﬀspring that were PCR positive for BVDV
and for which samples were available were subjected to IHC for
BVDV as described previously (Bachofen et al., 2014).
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FIGURE 1 | Reactivity of wild rabbit serum to bovine viral diarrhea (BVD) virus antigen. The sample to positive (S/P) value (vertical axis) for each sample
tested was plotted. Control positive serum (leftmost sample 1) has an S/P value of 1 while control negative serum (sample 2) has a value of 0. The geographic source
of samples is indicated beneath the chart, with year of collection for Perth samples. Samples from Yorkshire were collected between 2007 and 2014; samples from
Coll were collected between 2008 and 2012. The position of the S/P value cut-off for these samples (0.13) is indicated by a horizontal line. Samples that gave S/P
values >0.13 are indicated by asterisks (∗).
Statistical Analysis
Analysis of BVDV-speciﬁc antibody responses between the
two groups of infected rabbits was by Student’s t-test (two-
tailed, assuming equal variance between the two datasets), while
comparisons of infection levels between groups was by Fisher’s
exact test (two tailed; Fisher, 1922). Seroprevalence estimates
were made using Epitools epidemiological calculators (Sergeant,
2015; http://epitools.ausvet.com.au.) and conﬁdence intervals
(CIs) were calculated by the Binomial (Clopper–Pearson) ‘exact’
method within Epitools.
Results
Serological Analysis of Wild Rabbit Samples
Rabbit serum samples were tested for BVDV-speciﬁc antibodies
using an indirect ELISA modiﬁed for use with rabbit serum,
as described previously (Bachofen et al., 2014). The results of
this serosurvey are summarized in Figure 1. We have previously
shown that rabbits infected by non-parenteral routes developed
BVDV-speciﬁc antibody responses with S/P values ranging from
0.1 to 1.2 (Bachofen et al., 2014). Among the free-ranging wild
rabbit samples tested, the mean S/P value was 0.01 and a cut-oﬀ
of 0.13 was used to identify potential positive samples. Eleven
samples with S/P values greater than 0.1 were retested and of
these, four samples remained above 0.1 and three samples had S/P
values above 0.13 in both tests. Positive samples originated from
Yorkshire (n = 1) and Perthshire (n = 2). From this analysis the
frequency of BVDV-seropositive rabbits in the areas surveyed is
estimated at 3.2% (95% CI 0.1–16.7%) for Yorkshire; 0% (95% CI
0.0–7.9%) for Coll; and 1.1% (95% CI 0.1–3.9%) for Perthshire.
Although the three sampled areas are geographically distinct,
there is no signiﬁcant diﬀerence between regional prevalence
estimates and the overall prevalence estimate was 1.2% (95% CI
0.2–3.4%).
Infection of Pregnant Rabbits
To determine whether rabbits could be infected by BVDV in
utero, pregnant rabbits were challenged with a BVDV type
1a strain that had previously been shown to induce transient
infection of rabbits by parenteral and natural routes (Bachofen
et al., 2014). Details of the Groups, litter sizes and survival
are given in Table 1. One dam in Group 2 did not produce
a litter, while three oﬀspring in Group 1, three in Group 2
and one in Group 3 were stillborn. Due to the potential for
resorption or abortion of oﬀspring caused by the stress of
transport, handling, treatments and sampling, the pregnant dams
and their live oﬀspring were not sampled until the end of
the experiment (10 days after the birth of the ﬁrst litters). At
this point all surviving animals were euthanized and subject to
post-mortem examination. About half of the live-born oﬀspring
appeared to be killed by the dams and some were partially
eaten (Table 1). All dead animals and placentas were removed
when they were detected and tissue samples were collected where
possible.
Serology
Terminal serum samples from all dams were tested by BVDV-
speciﬁc ELISA to demonstrate seroconversion (compared to
seronegative pre-infection samples), which was used as indicator
of successful infection. All oﬀspring, where a terminal serum
sample could be obtained, were tested in the same way to
demonstrate presence of BVDV-speciﬁc antibodies, without
distinction between maternal antibodies or antibodies generated
by the oﬀspring. The S/P values of the terminal samples are
shown in Figure 2 and summarized in Table 2. A cut-oﬀ
for samples to be considered positive was calculated from
Group 3 as the mean S/P value plus three standard deviations
(0.2). The data show that dams in Groups 1 and 2 responded
to BVDV infection with a mean S/P value of 0.57. The
timing of infection did not have a signiﬁcant eﬀect on the
terminal titre, although the Group 1 dams (infected at day
7 after mating) appeared to have a lower mean S/P value
(0.40) than dams in Group 2 (0.75) that were infected 5 days
later.
Notably, not all of the dams appeared to respond strongly
to infection in challenge Groups 1 and 2. Several had low
S/P values (e.g., KPXD, KRRH; Table 2), suggesting that the
challenge or the immune response may have been sub-optimal
in some animals. However, most of these animals had other
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TABLE 1 | Details of groups and number of animals.
Group (n)a Challengedb Littersc Daysd Total offspring Stillborn Survivede
1 (8) Day 7 8 30–32 67 3 41 (61%)
2 (7) Day 12 6 32 44 3 18 (41%)
3 (3) Day 12 (Mock) 3 30–31 20 1 10 (50%)
aGroup number and number of animals (n) in each study group from which results were obtained.
bDay (post-mating) on which challenged. Mock-challenged animals received culture medium only.
cNumber of animals that delivered litters.
dDay on which litters delivered (days post mating).
eNumber of offspring (and percentage of group total) that survived until the end of the experiment (at least 10 days after birth).
FIGURE 2 | Reactivity of BVDV-infected rabbits and their offspring to BVDV antigen. S/P values (vertical axis) of terminal serum samples from all tested dams
and offspring (horizontal axis) are plotted. Dams are identified by their four-letter ear-tag codes, while the tested offspring follow the respective dams, identified by
single letters or numbers depending on their survival, as described in Table 2. Experimental group is indicated within each chart. The position of the S/P value cut-off
for these samples (0.2) is indicated by a horizontal line on each chart. All offspring tested here by ELISA were also tested by RT-PCR and positive RT-PCR results are
indicated by an asterisk above the relevant column (∗).
evidence of infection, such as BVDV RNA detected in placenta
or oﬀspring.
Pathology in Infected Rabbits
No lesions suggestive of BVDV infection were present on
examination of H&E sections of any dams or available oﬀspring.
Immunohistochemistry
Fixed tissues were only available from the dams and those
oﬀspring that survived to the end of the experiment (numbered
oﬀspring, Table 2) and of these, animals KPOT-5, KPTX-4 and
KPXB-2 were found to be positive in tissues for BVDV by RT-
PCR, whilst additional animals KPXD-2, KROJ-6, and KPXB-1
were RT-PCR positive in serum (Figure 2). Sections of all ﬁxed
tissues from these six animals only were tested for the presence
of pestivirus-speciﬁc antigen as described previously (Bachofen
et al., 2014). Repeated attempts at IHC gave inconsistent
results in the negative control rabbit preparations making
interpretation meaningless. Positive and negative controls using
BVDV-infected cattle tissue sections gave unequivocal staining
patterns, suggesting that the problems were due to the rabbit-
speciﬁc secondary reagent.
Detection of Viral RNA
RNA was extracted from placentas recovered from three
rabbits in Group 1, six rabbits in Group 2 and two rabbits
in Group 3. These samples were assayed for the presence
of BVDV-speciﬁc RNA by real-time RT-PCR. The results of
these assays are summarized in Table 2 and showed that
two animals from Group 1 and four animals from Group
2 shed placentas that contained BVDV RNA. There was
no clear association between the detection of BVDV-speciﬁc
RNA and the terminal BVDV-speciﬁc antibody titre in the
dams.
Serum and tissues from most oﬀspring were tested for the
presence of BVDV RNA by RT-PCR. Where available, serum
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TABLE 2 | Outcome of diagnostic analysis.
Animala (group) Placentab Offspringc Offspring BVDV RT-PCR tissued Offspring BVDV RT-PCR serum (urine)e Serology (offspring)f
POS NEG POS NEG
KRRH (1) – A,B; 1–3 A B,1,2,3 A,(B),1,2,3 0.06 (+)
KRUB (1) – A–C; 1–5 B 1,4,5 (B) (A),1,2,3,4,5 0.46 (+)
KPOT (1) 29 A,C; 1–7 5 A,1,2,3,4,6 A C,1,2,3,4,5,6 0.71 (+)
KPSA (1) – A-D; 1–6 1,2 A,B,C,1,2,3 0.18 (−)
KPTO (1) NEG A,B; 1–4 1,2 B,1,2,3,4 0.93 (+)
KPTX (1) 28 A–D; 1–6 B,4 C,D,1,2,3,5 B A,(C),D,1,2,3,4,5 0.72 (+)
KPXC (1) – A–D; 1–6 A,C 1,2,5,6 B,1,2,3,4,5,6 0.16 (−)
KPXD (1) – A,B,C,E,F; 1–4 A,D,F 1,2,3,4 A,F,2 B,C,E,1,3,4 0.00 (+)
KRUC (2) NEG A–H A,B C A,B,D,(E,G,H) 1.11 (+)
KROJ (2) 31 A; 1–6 1,2,3,4,5,6 6 (A),1,2,3,4,5,6 0.84 (+)
KRDL (2) 26 A; 1–6 A 1,2,3,4 (A) 1,2,3,4 0.20 (−)
KPNB (2) 31 A–G E,G A,B,C,D,F A,(E),G B,(C,D),F 0.73 (+)
KPXB (2) NEG A–C; 1–6 A,C,2 1,3,4,5,6 A,C,1,2 B,3,4,5,6 0.79 (+)
KPXI (2) – No litter 0.65 (0)
KROS (2) 29 A–F B A,C,D,E,F (A,C,D,E,F) 0.96 (0)
KRNP (3) – A,B; 1–4 A,B,3,4 1,2,3,4 0.00 (−)
KPYP (3) NEG A-G A,B (A,B,C,D,E,F),G 0.03 (−)
KPSX (3) NEG A; 1–6 1,2 A,1,2,3,4,5 0.02 (−)
aAnimal identifier for each pregnant dam sourced, with experimental group in parenthesis.
bDetection of BVDV-specific RNA in recovered placentas by real-time RT-PCR. Numbers indicate threshold cycle (Ct) values for detection of BVDV; NEG indicates that no
specific amplification was found; – indicates that no tissue was available for analysis.
cOffspring which died before day 8 are given as letters, while offspring that survived until the end of the experiment are denoted by numbers.
dTissue from at least two offspring in each litter were assayed for BVDV-specific RNA by real-time RT-PCR (appendix in all tested except KROS-B and KPOT-A, from
which kidney was used). POS indicates detection of BVDV with Ct of 22–25; NEG indicates that no specific amplification was found for the listed offspring.
edetection of BVDV-specific RNA in serum of offspring by direct end-point RT-PCR or by BVDV-specific real-time RT-PCR. POS indicates detection of BVDV-specific
amplicon; NEG indicates that no specific amplification was found for the listed offspring. Where no serum was available, urine was tested by the same method and these
results are given in parenthesis. All of the adults were negative for BVDV-specific RT-PCR in serum collected before infection and at port-mortem examination.
fBovine viral diarrhea-specific antibody responses were calculated for each animal from a post mortem blood sample (Figure 2). The S/P value for each dam is given,
while the detection of at least one offspring sample with BVDV-specific antibodies (S/P > 0.2) is indicated by (+). Where all tested offspring were BVDV antibody negative,
this is shown as (−). A lack of testable samples is indicated by (0).
(or urine) from each animal was tested in a direct end-point
PCR assay as described previously (Bachofen et al., 2013b) and
these results were repeated where possible by real-time RT-
PCR analysis of RNA extracted from serum or urine. Of 117
samples tested, 23 samples were found to be positive (Table 2).
To conﬁrm these results, RNA was prepared from tissues of at
least two oﬀspring from each litter, including all of the oﬀspring
found to be potentially positive by direct RT-PCR. RNA was
prepared from appendix where available and from kidney in
two cases where appendix could not be recovered. These RNA
samples were tested by real-time RT-PCR and showed that
the majority of RNA samples from tissues of oﬀspring with
positively testing serum or urine were also positive by real-
time RT-PCR, with Ct values of between 21 and 23; while
a small number of real-time RT-PCR positive samples were
from tissues of oﬀspring that were BVDV-negative by direct
PCR.
It is notable that most of the samples with detectable BVDV
RNA came from oﬀspring that were killed by their mothers
prior to day 8 after birth. Within the challenged groups,
16 of 52 killed oﬀspring had RT-PCR evidence of BVDV
infection while only seven positive samples were found among
the 59 oﬀspring that survived to the end of the experiment
(p< 0.02).
All of the oﬀspring that could be tested for serum
antibodies against BVD antigens were also tested by RT-
PCR for the presence of viral RNA (Figure 2). RT-PCR-
negative serum samples had S/P values ranging from zero
to 0.76; while RT-PCR-positive samples had S/P values from
zero to 0.64. There was no clear correlation between the
presence of detectable viral RNA in serum and the antibody
response.
Discussion
The aim of this study was to gather evidence to address the
possibility that BVDV-infected rabbits could form a wildlife
reservoir and be a risk of re-infection for cattle herds which were
free of BVDV and unvaccinated. Serological analysis ofmore than
250 samples from Yorkshire, Coll and Perth showed that only
three samples had S/P values that may represent BVDV-speciﬁc
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antibody responses (Figure 1). These samples, however, exhibited
high non-speciﬁc binding of the negative control antigen in the
ELISA and could therefore be false positives. Positive samples
could be the result of infection with BVDV, although cross
reactivity with other pestiviruses due to antigenic relatedness
is also formally possible (Ridpath, 2013). The low frequency of
positive samples (1.2%) suggests that BVDV is not established as
an endemic infection of rabbits in the UK regions tested and is
therefore likely to present a small risk of infection to in-contact
livestock.
We have previously demonstrated that rabbits can be
productively infected with BVDV type 1a (Bachofen et al., 2014)
with virus propagation detected in gut-associated lymphoid
tissue and with the development of virus-speciﬁc and virus-
neutralizing antibody responses. In this study, BVDV viral RNA
was detected in rabbits at day 5 after infection but not 3 weeks
later, when the animals had seroconverted. To investigate the
possibility that infection of pregnant rabbits might lead to the
generation of BVDV PI oﬀspring, two groups of rabbits were
infected with BVDV1a on day 7 and on day 12 after mating.
Following previous results (Bachofen et al., 2014) we would
expect the period of potential virus shedding from the dams
to have ceased by the end of gestation (23 days after day
7 and 18 days after day 12). Thus the detection of BVDV
RNA in the oﬀspring of 80% of infected rabbits is most
likely to be the result of trans-placental infection. However
the deﬁnition of persistent infection by BVDV is based on
immune tolerance of the virus and its presence in multiple
tissues and body ﬂuids. While BVDV RNA was detected in
serum (or urine) of some oﬀspring, the presence of BVDV-
speciﬁc antibodies in several RT-PCR-positive sera (Figure 2)
may be the result of maternal transfer or of the immune
response by oﬀspring to intra-uterine infection, suggestive of
possible transient infection. Further work is required to clarify
this.
Of the 15 animals challenged, 14 produced litters, suggesting
minimal ill-eﬀects of the transport and infection of the animals.
Indeed, the frequency of litters (17 of 18 dams delivered litters
with an average litter size of 7.3) was higher than the supplier’s
predicted level of 80% and the frequency of stillbirth among
the litters was unaﬀected by group (Table 1). However, about
half of the oﬀspring (47%) were killed by the dams in the
period up to day 8 after birth, after which all remaining
oﬀspring survived to the end of the experiment. In Group
1, 39% of the oﬀspring were killed, compared to 59% of
Group 2 oﬀspring and 50% of the control group, and this
diﬀerence was signiﬁcant between Groups 1 and 2 (p < 0.04).
This implies that the handling and/or challenge procedures at
day 12 of gestation had a signiﬁcant negative association with
survival of the oﬀspring. This appears to be a higher rate of
neonatal mortality than in a comparable commercial system
(individually housed dams), which showed average litter size of
9.6 and pre-weaning mortality of 15% (Szendro and McNitt,
2012).
It was also notable that the surviving oﬀspring included
signiﬁcantly fewer animals that were RT-PCR positive after
testing of serum and tissue samples than the oﬀspring that were
found dead (p < 0.02). This may suggest that infected oﬀspring
are preferentially killed or, alternatively, that transplacental
BVDV infection of neonatal rabbits is cleared within the
ﬁrst 10 days after birth, i.e., only in those animals that
survived long enough. There was, however, no correlation
between the level of BVDV-speciﬁc antibodies in the oﬀspring
and the detection of viral RNA, suggesting that circulating
antibodies in the oﬀspring did not protect them from viraemia,
although they may contribute to the resolution of BVDV
infection.
It was unclear in this study whether the BVDV-speciﬁc
antibodies detected in the oﬀspring were the result of maternal
transfer or were generated in the oﬀspring following in utero
infection. Rabbits are immunocompetent at birth but have a
restricted antibody repetoire, which continues to diversify up to
about 8 weeks of life (Knight and Winstead, 1997). However, it
is notable that the two infected dams with the lowest S/P values
(KRRH and KPXD; 0 and 0.06, respectively; Table 2) delivered
oﬀspring with higher S/P values, while all of the other infected
dams had higher S/P values than their oﬀspring (Figure 2). These
distinct patterns suggest that maternal transfer of antibodies may
not be the only method by which the oﬀspring gain BVDV-
speciﬁc antibodies.
The immunohistochemical analysis performed on tissue
samples from RT-PCR positive oﬀspring was inconclusive.
Greater binding of the labeled secondary antibody to the
cytoplasm of epithelia of the appendices and renal medullae was
observed in negative control preparations suggesting that goat
derived antibodies bound to these rabbit tissues in a non-BVDV
antigen mediated manner. Further work is required to optimize
these methods for use in rabbits.
The results of this study suggest that while trans-placental
infection of BVDV can occur in rabbits, relatively few of
the oﬀspring (21%) have evidence of infection from RT-
PCR of tissue or body ﬂuids. This supports the serological
data that BVDV infection of free-ranging wild rabbits
in the UK is infrequent. However, it is not clear from
these data whether the infected rabbits were PI in the
manner understood for livestock, as this would require
further testing at multiple time points. It would also be
beneﬁcial to perform longer-term studies on rabbits trans-
placentally infected with BVDV to determine whether
they shed virus or generate a BVDV-speciﬁc antibody
response. Although the proportion of infected oﬀspring
appears lower in rabbits than in cattle, the proportion of
births resulting in infected oﬀspring was high, particularly
for challenge at day 12 of gestation, which led to the
birth of infected oﬀspring in every litter. This could
contribute to maintaining presence of the virus in the
rabbit population. The reduced survival of virus-positive
oﬀspring compared to virus-negative oﬀspring, however,
would limit the opportunity for transmission. The overall
seroprevalence of BVDV in rabbits was low but, if the
seropositive results represent true positives, 1% of the
rabbit population would still translate into a large number
of animals, suggesting a non-zero risk of transmission.
Furthermore, conﬁdence intervals for prevalence estimates
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in geographically distinct areas covered a wide range and it is
conceivable that seroprevalence may be high in speciﬁc areas,
as previously suggested by Frolich and Streich (1998) based on
ﬁeld studies in Germany. In summary, there is a non-zero risk
of BVDV infection in rabbits and although this is unlikely to be
of epidemiological relevance for most control scenarios, it may
theoretically play a role in the tail end of an eradication campaign,
particularly in agricultural systems with a high likelihood of
contact between cattle and rabbits.
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